Oppenheimer & Co. Inc. Takes Position in Crescent Capital BDC, Inc. (NASDAQ:CCAP)

Oppenheimer & Co. Inc. bought a new stake in shares of Crescent Capital BDC, Inc. (NASDAQ:CCAP) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 13,577 shares of the company’s stock, valued at approximately $261,000.

Other hedge funds have also recently made changes to their positions in the company. Ieq Capital LLC raised its position in Crescent Capital BDC by 2.6% in the 4th quarter. Ieq Capital LLC now owns 22,725 shares of the company’s stock worth $437,000 after purchasing an additional 584 shares during the period. Confluence Investment Management LLC raised its position in Crescent Capital BDC by 0.9% in the 4th quarter. Confluence Investment Management LLC now owns 73,839 shares of the company’s stock worth $1,419,000 after purchasing an additional 633 shares during the period. HighTower Advisors LLC raised its position in Crescent Capital BDC by 0.5% in the 3rd quarter. HighTower Advisors LLC now owns 141,838 shares of the company’s stock worth $2,624,000 after purchasing an additional 768 shares during the period. Denali Advisors LLC raised its position in Crescent Capital BDC by 0.5% in the 4th quarter. Denali Advisors LLC now owns 183,783 shares of the company’s stock worth $3,532,000 after purchasing an additional 855 shares during the period. Finally, Van ECK Associates Corp raised its position in Crescent Capital BDC by 2.3% in the 4th quarter. Van ECK Associates Corp now owns 45,562 shares of the company’s stock worth $876,000 after purchasing an additional 1,006 shares during the period. 49.46% of the stock is currently owned by hedge funds and other institutional investors.

Crescent Capital BDC Price Performance

Shares of CCAP stock opened at $17.37 on Friday. The company has a debt-to-equity ratio of 1.18, a current ratio of 1.32 and a quick ratio of 1.26. The company has a market capitalization of $643.77 million, a P/E ratio of 8.73 and a beta of 0.82. The company’s 50-day simple moving average is $19.08 and its two-hundred day simple moving average is $18.87. Crescent Capital BDC, Inc. has a one year low of $16.85 and a one year high of $20.19.

Crescent Capital BDC (NASDAQ:CCAP) last issued its earnings results on Wednesday, February 19th. The company reported $0.55 EPS for the quarter, missing analysts’ consensus estimates of $0.56 by ($0.01). The company had revenue of $46.40 million during the quarter, compared to the consensus estimate of $47.27 million. Crescent Capital BDC had a return on equity of 11.90% and a net margin of 37.32%. As a group, equities analysts anticipate that Crescent Capital BDC, Inc. will post 2.09 EPS for the current year.

Crescent Capital BDC Announces Dividend

The firm also recently disclosed a dividend, which will be paid on Friday, March 14th. Stockholders of record on Friday, February 28th will be paid a dividend of $0.05 per share. The ex-dividend date of this dividend is Friday, February 28th. Crescent Capital BDC’s dividend payout ratio is presently 84.42%.

Analysts Set New Price Targets

A number of research firms recently weighed in on CCAP. Keefe, Bruyette & Woods increased their price objective on shares of Crescent Capital BDC from $19.00 to $20.00 and gave the stock an “outperform” rating in a research report on Monday, November 25th. Wells Fargo & Company reduced their price objective on shares of Crescent Capital BDC from $19.00 to $18.00 and set an “equal weight” rating on the stock in a research report on Friday, February 21st. One equities research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Crescent Capital BDC currently has a consensus rating of “Moderate Buy” and an average target price of $19.20.

About Crescent Capital BDC

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.